...
首页> 外文期刊>Prostaglandins, Leukotrienes, and Essential Fatty Acids >Red blood cell fatty acid profile of chronic renal failure patients receiving maintenance haemodialysis treatment.
【24h】

Red blood cell fatty acid profile of chronic renal failure patients receiving maintenance haemodialysis treatment.

机译:接受维持性血液透析治疗的慢性肾衰竭患者的红细胞脂肪酸谱。

获取原文
获取原文并翻译 | 示例
           

摘要

The fatty acid profile of chronic renal failure (CRF) patients on maintenance haemodialysis treatment (MHT) is abnormal and results point towards an essential fatty acid (EFA) deficiency. However, controversies still exist as to which of the essential fatty acids (EFAs) or EFA-products are decreased. In this study, the results of a comprehensive analysis of the fatty acids, performed on the red blood cells of 14 CRF patients on MHT, are presented. The red blood cell membrane fatty acids determined in this study include a range of saturated fatty acids (SFAs), mono-unsaturated fatty acids (MUFAs) and poly-unsaturated fatty acids (PUFAs). Results confirmed the suggested presence of an essential fatty acid deficiency in CRF patients on MHT. It showed the total content of the n-6 fatty acids (31.66+/-3.21 vs 34.67+/-2.05), as well as the total content of the PUFAs (37.22+/-4.08 vs 40.93+/-2.35), to be significantly decreased. The total MUFA content was, in contrast, significantly increased (16.87+/-0.91 vs 15.49+/-1.18). The EFA deficiency profile seen in this study points towards that of a chronic inflammatory condition. This is borne out by the fact that all three precursors of the eicosanoids-the mediators of various inflammatory and immune responses-were reduced in the presence of an increase in MUFAs as well as SFAs. The possibility of the fatty acid profile of CRF patients on MHT being that of a chronic inflammatory condition is supported by the fact that continuous complement-dependent and complement-independent immune activation, due to bio-incompatibility between blood cells and the dialysis membranes, is known to occur during the dialysis process.
机译:维持性血液透析治疗(MHT)的慢性肾衰竭(CRF)患者的脂肪酸谱异常,结果表明必需脂肪酸(EFA)缺乏。但是,关于减少哪些必需脂肪酸(EFA)或EFA产品仍然存在争议。在这项研究中,提出了对14名CRF患者的MHT的红细胞进行的脂肪酸综合分析的结果。在这项研究中确定的红细胞膜脂肪酸包括一系列饱和脂肪酸(SFA),单不饱和脂肪酸(MUFA)和多不饱和脂肪酸(PUFA)。结果证实了建议的MHT CRF患者存在必需脂肪酸缺乏症。它显示了n-6脂肪酸的总含量(31.66 +/- 3.21对34.67 +/- 2.05)以及PUFA的总含量(37.22 +/- 4.08对40.93 +/- 2.35)。被大大减少。相反,总的MUFA含量显着增加(16.87 +/- 0.91对15.49 +/- 1.18)。在这项研究中看到的EFA缺乏状况表明是慢性炎症性疾病。这通过事实证明,在MUFA和SFA增加的情况下,类花生酸的所有三种前体-各种炎症和免疫反应的介体-都减少了。由于血细胞和透析膜之间的生物不相容性,持续补体依赖性和补体依赖性免疫激活被以下事实支持,CRF患者在MHT上的脂肪酸谱可能是慢性炎症性疾病:已知发生在透析过程中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号